Alachkar, Houda
- University of Southern California · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #13,531
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$794.2K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#13,531
By linked amount among FY2023 PIs
Earliest Year Loaded
2021
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Alachkar, Houda as a PI. Multi-PI records show the full award amount for context.
- 1R21CA274416-01A1R21Contact PIMitochondrial Dysfunction underlies treatment related hepatotoxicity in Hispanics with acute lymphoblastic leukemiaUniversity of Southern California · Pharmacology (NIH department code)$442.4Kaward amount
- 5R01CA248381-03R01Contact PILeveraging the TCR Repertoire to identify target neoantigens in FLT3-ITD positive Acute Myeloid LeukemiaUniversity of Southern California · Pharmacology (NIH department code)$351.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Alachkar, Houda as a PI.
FY2023 award administered by University of Southern California (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardUniversity of Southern California
- 2022$500K Cumulative Funding
- 2022R01 Grant Holder
- 2023$1M Cumulative Funding